Seizure control by ketogenic diet-associated medium chain fatty acids

Neuropharmacology

Volumn 69, Issue , 2013, Pages 105-114

  Chang, Pishan ^a   Terbach, Nicole ^a   Plant, Nick ^b   Chen, Philip E ^a   Walker, Matthew C ^c   Williams, Robin S B ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Medium chain triglyceride (MCT) ketogenic diet; Neuroprotection; Seizure control; Teratogenicity; Valproic acid (VPA)

Indexed keywords

HISTONE DEACETYLASE; MEDIUM CHAIN FATTY ACID; TRIACYLGLYCEROL; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BENIGN CHILDHOOD EPILEPSY; DISEASE CONTROL; DRUG POTENCY; IN VITRO STUDY; IN VIVO STUDY; KETOGENIC DIET; LIVER TOXICITY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SEIZURE; TERATOGENICITY;

ANIMALS; ANTICONVULSANTS; CAPRYLATES; CELL LINE; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG-INDUCED LIVER INJURY; FATTY ACIDS; HISTONE DEACETYLASES; HUMANS; HYPNOTICS AND SEDATIVES; KETOGENIC DIET; MALE; PENTYLENETETRAZOLE; PHEROMONES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; STATUS EPILEPTICUS; VALPROIC ACID;

EID: 84875235362     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.11.004     Document Type: Article

References (62)

1. 2+ in rat entorhinal cortex-hippocampus slices Epilepsy Res. 32 1998 345 355
2. J. Beare-Rogers, A. Dieffenbacher, and A.V. Holm Lexicon of lipid nutrition (IUPAC technical report) Pure Appl. Chem. 73 2001 685 744
3. A.M.M. Berrie, R. Don, D. Buller, A. Alam, and W. Parker The occurrence and function of short chain length fatty acids in plants Plant Sci. Lett. 6 1975 163 173
4. M. Bialer, and H.S. White Key factors in the discovery and development of new antiepileptic drugs Nat. Rev. Drug Discov. 9 2010 68 82
5. U. Bojic, M.M.A. Elmazar, R.S. Hauck, and H. Nau Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect Chem. Res. Toxicol. 9 1996 866 870
6. C.P. Brennand, and R.C. Lindsay Distribution of volatile branched-chain fatty acids in various lamb tissues Meat Sci. 31 1992 411 421
7. J. Brill, M. Lee, S. Zhao, R.D. Fernald, and J.R. Huguenard Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami J. Neurosci. 26 2006 6813 6822
8. P.S. Buckmaster, and A.L. Jongen-Relo Highly specific neuron loss preserves lateral inhibitory circuits in the dentate gyrus of kainate-induced epileptic rats J. Neurosci. 19 1999 9519 9529
9. P. Chang, K.E. Chandler, R.S. Williams, and M.C. Walker Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP Epilepsia 51 2010 1533 1542
10. P. Chang, B. Orabi, R.M. Deranieh, M. Dham, O. Hoeller, J.A. Shimshoni, B. Yagen, M. Bialer, M.L. Greenberg, M.C. Walker, and R.S. Williams The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium Dis. Model. Mech. 5 2011 115 124
11. A.G. Chapman, and B.S. Meldrum Effects of anticonvulsant drugs on brain amino acid metabolism Prog. Clin. Biol. Res. 124 1983 63 76
12. A.M. Dam Epilepsy and neuron loss in the hippocampus Epilepsia 21 1980 617 629
13. N.C. de Lanerolle, J.H. Kim, R.J. Robbins, and D.D. Spencer Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy Brain Res. 495 1989 387 395
14. D. Eikel, A. Lampen, and H. Nau Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives Chem. Res. Toxicol. 19 2006 272 278
15. L.M. Elphick, N. Pawolleck, I.A. Guschina, L. Chaieb, D. Eikel, H. Nau, J.L. Harwood, N.J. Plant, and R.S. Williams Conserved valproic acid-induced lipid droplet formation in Dictyostelium and human hepatocytes (huh7) identifies structurally active compounds Dis. Model. Mech. 5 2011 231 240
16. A. Fisher, X. Wang, H.R. Cock, M. Thom, P.N. Patsalos, and M.C. Walker Synergism between topiramate and budipine in refractory status epilepticus in the rat Epilepsia 45 2004 1300 1307
17. J. Freeman, P. Veggiotti, G. Lanzi, A. Tagliabue, and E. Perucca The ketogenic diet: from molecular mechanisms to clinical effects Epilepsy Res. 68 2006 145 180
18. H. Fujimura, N. Murakami, M. Kurabe, and W. Toriumi In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis J. Appl. Toxicol. 29 2009 356 363
19. R.H. Furman, R.P. Howard, O.J. Brusco, and P. Alaupovic Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia J. Lab. Clin. Med. 66 1965 912 926
20. A.S. Galanopoulou, P.S. Buckmaster, K.J. Staley, S.L. Moshe, E. Perucca, J. Engel Jr., W. Loscher, J.L. Noebels, A. Pitkanen, J. Stables, H.S. White, T.J. O'Brien, and M. Simonato Identification of new epilepsy treatments: issues in preclinical methodology Epilepsia 53 2012 571 582
21. M. Gasior, M.A. Rogawski, and A.L. Hartman Neuroprotective and disease-modifying effects of the ketogenic diet Behav. Pharmacol. 17 2006 431 439
22. M. Gottlicher, S. Minucci, P. Zhu, O.H. Kramer, A. Schimpf, S. Giavara, J.P. Sleeman, C.F. Lo, C. Nervi, P.G. Pelicci, and T. Heinzel Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J. 20 2001 6969 6978
23. N. Gurvich, O.M. Tsygankova, J.L. Meinkoth, and P.S. Klein Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res. 64 2004 1079 1086
24. J.K. Ha, and R.C. Lindsay Release of volatile branched-chain and other fatty acids from ruminant milk fats by various lipases J. Dairy Sci. 76 1993 677 690
25. D. Haidukewych, W.I. Forsythe, and M. Sills Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet Clin. Chem. 28 1982 642 645
26. M. Holtkamp, X. Tong, and M.C. Walker Propofol in subanesthetic doses terminates status epilepticus in a rodent model Ann. Neurol. 49 2001 260 263
27. X. Hou, X. Wang, and L. Zhang Conditional downregulation of brain-derived neurotrophic factor and tyrosine kinase receptor B blocks epileptogenesis in the human temporal lobe epilepsy hippocampus Neurol. India 58 2010 29 34
28. P.R. Huttenlocher, A.J. Wilbourn, and J.M. Signore Medium-chain triglycerides as a therapy for intractable childhood epilepsy Neurology 21 1971 1097 1103
29. J. Jentink, M.A. Loane, H. Dolk, I. Barisic, E. Garne, J.K. Morris, and L.T. de Jong-van den Berg Valproic acid monotherapy in pregnancy and major congenital malformations N. Engl. J. Med. 362 2010 2185 2193
30. P.E. Keane, J. Simiand, E. Mendes, V. Santucci, and M. Morre The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice Neuropharmacology 22 1983 875 879
31. G. Koren, A.A. Nava-Ocampo, M.E. Moretti, R. Sussman, and I. Nulman Major malformations with valproic acid Can. Fam. Physician 52 2006 441-442, 444, 447
32. E.H. Kossoff, B.A. Zupec-Kania, and J.M. Rho Ketogenic diets: an update for child neurologists J. Child. Neurol. 24 2009 979 988
33. D.C. Lagace, W.T. O'Brien, N. Gurvich, M.W. Nachtigal, and P.S. Klein Valproic acid: how it works. Or not Clin. Neurosci. Res. 4 2005 215 225
34. V.C. Lee, J.C. Moscicki, and C.A. DiFazio Propofol sedation produces dose-dependent suppression of lidocaine-induced seizures in rats Anesth. Analg. 86 1998 652 657
35. S.S. Likhodii, K. Musa, A. Mendonca, C. Dell, W.M. Burnham, and S.C. Cunnane Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet Epilepsia 41 2000 1400 1410
36. W.G. Linscheer, J.F. Patterson, E.W. Moore, R.J. Clermont, S.J. Robins, and T.C. Chalmers Medium and long chain fat absorption in patients with cirrhosis J. Clin. Invest. 45 1966 1317 1325
37. M.J. Liu, and G.M. Pollack Pharmacokinetics and pharmacodynamics of valproate analogues in rats. IV. Anticonvulsant action and neurotoxicity of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid Epilepsia 35 1994 234 243
38. Y.M. Liu Medium-chain triglyceride (MCT) ketogenic therapy Epilepsia 49 Suppl. 8 2008 33 36
39. W. Loscher, and H. Nau Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice Neuropharmacology 24 1985 427 435
40. A.E. Nassar, A.M. Kamel, and C. Clarimont Improving the decision-making process in structural modification of drug candidates: reducing toxicity Drug Discov. Today 9 2004 1055 1064
41. E.G. Neal, H. Chaffe, R.H. Schwartz, M.S. Lawson, N. Edwards, G. Fitzsimmons, A. Whitney, and J.H. Cross A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy Epilepsia 50 2009 1109 1117
42. M.J. Newport, J.E. Storry, and B. Tuckley Artificial rearing of pigs. 7. Medium chain triglycerides as a dietary source of energy and their effect on live-weight gain, feed:gain ratio, carcass composition and blood lipids Br. J. Nutr. 41 1979 85 93
43. J. Palaty, and F.S. Abbott Structure-activity relationships of unsaturated analogues of valproic acid J. Med. Chem. 38 1995 3398 3406
44. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press New York
45. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, and P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J. Biol. Chem. 276 2001 36734 36741
46. J.M. Rho, and R. Sankar The ketogenic diet in a pill: is this possible? Epilepsia 49 Suppl. 8 2008 127 133
47. J.M. Rho, and C.E. Stafstrom The ketogenic diet: what has science taught us? Epilepsy Res. 100 3 2012 210 217
48. H.E. Scharfman Epileptogenesis in the parahippocampal region. Parallels with the dentate gyrus Ann. N. Y. Acad. Sci. 911 2000 305 327
49. M.A. Sills, W.I. Forsythe, and D. Haidukewych Role of octanoic and decanoic acids in the control of seizures Arch. Dis. Child. 61 1986 1173 1177
50. M.A. Sills, W.I. Forsythe, D. Haidukewych, A. MacDonald, and M. Robinson The medium chain triglyceride diet and intractable epilepsy Arch. Dis. Child. 61 1986 1168 1172
51. M.F. Silva, C.C. Aires, P.B. Luis, J.P. Ruiter, L. Ijlst, M. Duran, R.J. Wanders, and d.A.I. Tavares Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review J. Inherit. Metab. Dis. 2008
52. M.P. St-Onge, and P.J. Jones Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity J. Nutr. 132 2002 329 332
53. J.R. Stephens, and R.H. Levy Valproate hepatotoxicity syndrome: hypotheses of pathogenesis Pharm. Weekbl. Sci. 14 1992 118 121
54. M.M. Sutherland, and J.M. Ames Free fatty acids composition of the adipose tissue of intact and castrated lambs slaughtered at 12 and 30 weeks of age J. Agric. Food Chem. 44 1994 3113 3116
55. P. Thavendiranathan, A. Mendonca, C. Dell, S.S. Likhodii, K. Musa, C. Iracleous, S.C. Cunnane, and W.M. Burnham The MCT ketogenic diet: effects on animal seizure models Exp. Neurol. 161 2000 696 703
56. E.P. Vining, J.M. Freeman, K. Ballaban-Gil, C.S. Camfield, P.R. Camfield, G.L. Holmes, S. Shinnar, R. Shuman, E. Trevathan, and J.W. Wheless A multicenter study of the efficacy of the ketogenic diet Arch. Neurol. 55 1998 1433 1437
57. M.C. Walker, H. Perry, F. Scaravilli, P.N. Patsalos, S.D. Shorvon, and J.G. Jefferys Halothane as a neuroprotectant during constant stimulation of the perforant path Epilepsia 40 1999 359 364
58. H. Wallace, S. Shorvon, and R. Tallis Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy Lancet 352 1998 1970 1973
59. R.S. Williams, K. Boeckeler, R. Graf, A. Muller-Taubenberger, Z. Li, R.R. Isberg, D. Wessels, D.R. Soll, H. Alexander, and S. Alexander Towards a molecular understanding of human diseases using Dictyostelium discoideum Trends Mol. Med. 12 2006 415 424
60. R.S.B. Williams, L. Cheng, A.W. Mudge, and A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295
61. P. Wlaz, K. Socala, D. Nieoczym, J.J. Luszczki, I. Zarnowska, T. Zarnowski, S.J. Czuczwar, and M. Gasior Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice Neuropharmacology 62 2012 1882 1889
62. X. Xu, A. Muller-Taubenberger, K.E. Adley, N. Pawolleck, V.W. Lee, C. Wiedemann, T.S. Sihra, M. Maniak, T. Jin, and R.S. Williams Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid Eukaryot. Cell 6 2007 899 906